Wealth Manager - the site for professional investment managers

Register to get unlimited access to Citywire’s fund manager database. Registration is free and only takes a minute.

Vodafone and M&S disappointments drag FTSE lower

Vodafone and M&S disappointments drag FTSE lower

Vodafone (VOD) and Marks & Spencer (MKS) have dragged the FTSE lower after both companies unveiled disappointing results.

Vodafone shed 9.2p, or 4.2%, as it unveiled full-year earnings below investors expectations at £12.8 billion, 7.4% down on the previous year. Marks & Spencer meanwhile dropped 14.8p, or 3.3%, to 436.2p as the retailer reported a third year of falling earnings. The FTSE 100 slipped 33 points, or 0.5%, to 6,811.

Analysts at Jeffries said Vodafone's results contained 'little to inspire confidence in turnaround prospects', adding there was scant evidence of any improvement in revenues. They added that investment in Germany and the UK was weighing on margins and that in Germany in particular, results had been modest given the scale of the investment.

'Our operational performance has been mixed,' said Vodafone chief executive Vittorio Colao. 'In Europe, where we continue to face competitive, regulatory and macroeconomic pressures, we have taken steps to improve our commercial performance, particularly in Germany and Italy, and are beginning to see encouraging early signs.'

Declining revenues at Marks & Spencer, which made a pre-tax profit of £623 million in the year to 29 March, meant it fell behind fast growing rival Next (NXT) for the first time.

Having now launched a troubled new website, capital expenditure levels are set to fall, but investors are worried online difficulties could persist and are waiting to see if an improvement in performance follows. 'We need to see a sutained pick up in clothing performance and signs of market share recovery to take a more positive view on M&S,' said Peel Hunt analyst John Stevenson.

AstraZeneca (AZN) continued falling after yesterday's plunge following the pharmaceuctial giant's rejection of a 'final' takeover approach from US rival Pfizer. It fell a further 53p, or 1.2%, to £42.38 as investors appeared to accept any lingering hopes of the deal being revived were now dead.

Carnival (CCL) was the biggest riser on the FTSE 100, adding 112p, or 4.9%, to £24.14 as the cruise company announced plans to expand its Australian operations.

Leave a comment!

Please sign in or register to comment. It is free to register and only takes a minute or two.
Citywire TV
Play Biotech Growth: we will ride out this storm

Biotech Growth: we will ride out this storm

Geoffrey Hsu of Biotech Growth Trust says the sell-off in biotechnology stocks represents a buying opportunity for long-term investors.

Play Sector Spotlight: Kleinwort Benson's Choukeir on UK equities

Sector Spotlight: Kleinwort Benson's Choukeir on UK equities

In our first Sector Spotlight of the year we explore UK equities on the back of the extreme market turbulence in 2016.

Play Picton: the UK property hotspots for rental income

Picton: the UK property hotspots for rental income

Picton Property Income CEO Michael Morris reveals how he is planning to ride the ‘ripple effect’ as UK economic growth spills out from the capital across the country.

Your Business: Cover Star Club

Profile: PortfolioMetrix is on a mission to kill 'Frankenstein' systems

Profile: PortfolioMetrix is on a mission to kill 'Frankenstein' systems

In a buyers’ market for off-the-peg discretionary management, self-funded start-ups begin at an inherent disadvantage

Wealth Manager on Twitter